Genentech Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 11,724.0 | 9,284.0 | 6,633.4 |
| Cost of Goods Sold | 1,571.0 | 1,181.0 | 1,011.1 |
| Gross Profit | 10,153.0 | 8,103.0 | 5,622.3 |
| Gross Profit Margin | 86.6% | 87.3% | 84.8% |
| SG&A Expense | 5,432.0 | 4,544.0 | 3,330.3 |
| Depreciation & Amortization | 492.0 | 407.0 | 370.2 |
| Operating Income | 4,229.0 | 3,152.0 | 1,921.8 |
| Operating Margin | 36.1% | 34.0% | 29.0% |
| Nonoperating Income | 273.0 | 325.0 | 140.9 |
| Nonoperating Expenses | 76.0 | 74.0 | 49.9 |
| Income Before Taxes | 4,426.0 | 3,403.0 | 2,012.8 |
| Income Taxes | 1,657.0 | 1,290.0 | 733.9 |
| Net Income After Taxes | 2,769.0 | 2,113.0 | 1,279.0 |
| Continuing Operations | 2,769.0 | 2,113.0 | 1,279.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 2,769.0 | 2,113.0 | 1,279.0 |
| Total Net Income | 2,769.0 | 2,113.0 | 1,279.0 |
| Net Profit Margin | 23.6% | 22.8% | 19.3% |
| Diluted EPS from Total Net Income ($) | 2.59 | 1.97 | 1.18 |
| Dividends per Share | -- | -- | -- |






